Differential effects of short- and long-term hyperhomocysteinaemia on cholinergic neurons, spatial memory and microbleedings in vivo in rats.
Hyperhomocysteinaemia (HHcy) has been identified as a cardiovascular risk factor for neurodegenerative brain diseases. The aim of the present study was to investigate the effects of short (5 months) or long (15 months) HHcy in Sprague–Dawley rats in vivo. Short- and long-term HHcy differentially affected spatial memory as tested in a partially baited eight-arm radial maze. HHcy significantly reduced the number of choline acetyltransferase (ChAT)-positive neurons in the basal nucleus of Meynert and ChAT-positive axons in the cortex only after short-term but not long-term treatment, while acetylcholine levels in the cortex were decreased at both time points. Nerve growth factor (NGF) was significantly enhanced in the cortex only after 15 months of HHcy. HHcy did not affect cortical levels of amyloid precursor protein, beta-amyloid(1-42), tau and phospho-tau181 and several inflammatory markers, as well as vascular RECA-1 and laminin density. However, HHcy induced cortical microbleedings, as illustrated by intensive anti-rat IgG-positive spots in the cortex. In order to study the regulation of the key enzyme ChAT, organotypic rat brain slices were incubated with homocysteine, which induced a decline of ChAT that was counteracted by NGF treatment. In conclusion, our data demonstrate that chronic short- and long-term HHcy differentially caused memory impairment, cholinergic dysfunction, NGF expression and vascular microbleedings.
Laboratory of Psychiatry and Experimental Alzheimer’s Research, Department of Psychiatry and Psychotherapy, Innsbruck Medical, University, Anichstr. 35, A-6020 Innsbruck, Austria.
Michael
M
Pirchl
Celine
C
Ullrich
Christian
C
Humpel
D000109:Acetylcholine / Q000378:metabolism*; D000818:Animals; D020532:Basal Nucleus of Meynert / Q000378:metabolism; D001522:Behavior, Animal; D001812:Blood-Brain Barrier / Q000502:physiology; D002540:Cerebral Cortex / Q000378:metabolism / Q000473:pathology; D002560:Cerebrovascular Circulation; D002795:Choline O-Acetyltransferase / Q000378:metabolism; D006470:Hemorrhage / Q000503:physiopathology*; D020138:Hyperhomocysteinemia / Q000503:physiopathology*; D007858:Learning / Q000502:physiology; D008297:Male; D008568:Memory / Q000502:physiology*; D009414:Nerve Growth Factors / Q000378:metabolism; D009474:Neurons / Q000378:metabolism*; D009483:Neuropsychological Tests; D011897:Random Allocation; D051381:Rats; D017207:Rats, Sprague-Dawley; D046509:Tissue Culture Techniques
D009414:Nerve Growth Factors; D002795:Choline O-Acetyltransferase; D000109:Acetylcholine